Structure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.

Structure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.
复制标题

基于结构的四氢异喹啉-7-羧酰胺作为选择性盘状结构域受体1(DDR1)抑制剂的设计。

DOI:
10.1021/acs.jmedchem.6b00140
复制
发表时间:
2016-06-23
影响因子:
7.3
通讯作者:
Ding, Ke
Ding, Ke
中科院分区:
医学1区
文献类型:
--
作者:
Wang, Zhen;Bian, Huan;Bartual, Sergio G.;Du, Wenting;Luo, Jinfeng;Zhao, Hu;Zhang, Shasha;Mo, Cheng;Zhou, Yang;Xu, Yong;Tu, Zhengchao;Ren, Xiaomei;Lu, Xiaoyun;Brekken, Rolf A.;Yao, Libo;Bullock, Alex N.;Su, Jin;Ding, Ke

文献摘要

参考文献

被引文献

相似文献

报道了基于结构的1,2,3,4-四氢异喹啉衍生物选择性DDR 1抑制剂的设计。其中一种代表性化合物6 j与DDR 1结合的Kd值为4.7 nM,抑制其激酶活性的IC 50值为9.4 nM,但对一组400种非突变激酶的效力明显较低。6 j还在博来霉素诱导的小鼠肺纤维化模型中证明了合理的药代动力学性质和有希望的口服治疗效果。
The structure-based design of 1, 2, 3, 4-tetrahydroisoquinoline derivatives as selective DDR1 inhibitors is reported. One of the representative compounds, 6j, binds to DDR1 with a Kd value of 4.7 nM and suppresses its kinase activity with an IC50 value of 9.4 nM, but it is significantly less potent for a panel of 400 nonmutated kinases. 6j also demonstrated reasonable pharmacokinetic properties and a promising oral therapeutic effect in a bleomycin-induced mouse pulmonary fibrosis model.
DOI: 10.1016/b978-0-12-800180-6.00002-5
发表时间: 2014
影响因子: --
作者:
Leitinger, Birgit
通讯作者: Leitinger, Birgit
DOI: 10.1016/j.drudis.2014.09.025
发表时间: 2015-02
影响因子: 7.4
作者:
Kethiwale, Sandeepkumar;Borza, Corina M.;Lowe, Edward W., Jr.;Pozzi, Ambra;Meiler, Jens
通讯作者: Meiler, Jens
DOI: 10.1021/jm301824k
发表时间: 2013-04-25
影响因子: 7.3
作者:
Gao, Mingshan;Duan, Lei;Ding, Ke
通讯作者: Ding, Ke
DOI: 10.1016/j.ccr.2005.01.007
发表时间: 2005-02-01
期刊: CANCER CELL
影响因子: 50.3
作者:
Weisberg, E;Manley, PW;Griffin, JD
通讯作者: Griffin, JD
DOI: 10.1007/s10555-012-9346-z
发表时间: 2012-06
影响因子: 9.2
作者:
Valiathan, Rajeshwari R.;Marco, Marta;Leitinger, Birgit;Kleer, Celina G.;Fridman, Rafael
通讯作者: Fridman, Rafael